癌症病史对院外心脏骤停复苏后治疗的影响
本研究基于韩国全国前瞻性院外心脏骤停登记数据库,纳入2009至2016年所有推定心源性病因且复苏后持续自主循环恢复的成人患者,共33,760例,采用横断面观察性设计。主要暴露为癌症病史,主要结局为复苏后治疗,包括经皮冠状动脉介入治疗(PCI)和目标温度管理(TTM)。多变量逻辑回归分析显示,癌症患者接受PCI的调整优势比为0.29(95%CI:0.24-0.37),接受TTM的调整优势比为0.66(95%CI:0.58-0.77),均显著低于无癌症病史者。作者认为,既往癌症病史可能与接受潜在获益的复苏后治疗的概率较低相关。
要点
- 在33,760例院外心脏骤停复苏后持续ROSC的成人中,有癌症病史者接受PCI的调整优势比为0.29(95%CI:0.24-0.37),显著低于无癌症病史者。
- 有癌症病史者接受TTM的调整优势比为0.66(95%CI:0.58-0.77),显著低于无癌症病史者。
- 研究提示,既往癌症病史可能与接受潜在获益的复苏后治疗的概率较低相关。
适用人群与场景
- 韩国全国前瞻性院外心脏骤停登记数据库中2009至2016年的成人院外心脏骤停患者,推定心源性病因且复苏后持续自主循环恢复(ROSC)。
研究设计与关键结果
- 研究类型为基于全国前瞻性院外心脏骤停登记数据库的横断面观察性研究,最终分析纳入33,760例患者。
- 主要暴露为癌症病史,主要结局为复苏后治疗包括PCI和TTM。
- 多变量逻辑回归显示,癌症患者接受PCI的调整优势比为0.29(95%CI:0.24-0.37),接受TTM的调整优势比为0.66(95%CI:0.58-0.77),均显著低于无癌症病史者。
证据类型、等级与局限
- 证据类型为横断面观察性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,既往癌症病史可能与接受潜在获益的复苏后治疗的概率较低相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: There is growing evidence that optimal post-resuscitation treatment is a significant factor for overall survival and neurological outcomes in out-of-hospital cardiac arrest (OHCA). However, there is also growing evidence of disparities in treatments in vulnerable populations such as elderly individuals or patients with underlying diseases, including cancer.
AIM: The aim of this study was to evaluate the influence of cancer status on post-resuscitation therapies among OHCA patients.
MATERIAL AND METHODS: This was a cross-sectional observational study based on a nationwide prospective OHCA registry database of Korea. All adult OHCA patients with presumed cardiac etiology and sustained return of spontaneous circulation (ROSC) from 2009 to 2016 were included in this study. Main exposure was history of cancer and primary outcome was post-resuscitation care, including percutaneous coronary intervention (PCI) and targeted temperature management (TTM). Multivariable logistic regression was used to analyze the association between cancer and post-resuscitation treatments.
RESULTS: A total of 33,760 patients were included for final analysis. Multivariable logistic analysis showed that cancer patients were significantly less likely to receive PCI and TTM compared to those without history of cancer with adjusted odds ratios of 0.29 (95% CI: 0.24-0.37) and 0.66 (0.58-0.77), respectively.
CONCLUSION: The results of this study suggest that a prior history of cancer may be associated with lower probability to receive potentially beneficial post-resuscitation treatments.
参考来源
- Kang SB, Kong SYJ, Shin SD, et al. Effect of cancer history on post-resuscitation treatments in out-of-hospital cardiac arrest. Resuscitation. 2019. PMID: 30771449. doi:10.1016/j.resuscitation.2019.02.005
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。